Xiamen Amoytop Biotech Statistics
Total Valuation
SHA:688278 has a market cap or net worth of CNY 30.11 billion. The enterprise value is 29.43 billion.
| Market Cap | 30.11B |
| Enterprise Value | 29.43B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
SHA:688278 has 408.19 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 408.19M |
| Shares Outstanding | 408.19M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 50.20% |
| Owned by Institutions (%) | 14.10% |
| Float | 161.26M |
Valuation Ratios
The trailing PE ratio is 28.93 and the forward PE ratio is 20.61. SHA:688278's PEG ratio is 0.76.
| PE Ratio | 28.93 |
| Forward PE | 20.61 |
| PS Ratio | 8.15 |
| PB Ratio | 10.01 |
| P/TBV Ratio | 11.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.76 |
Enterprise Valuation
| EV / Earnings | 28.36 |
| EV / Sales | 7.96 |
| EV / EBITDA | 22.41 |
| EV / EBIT | 23.47 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.31% and return on invested capital (ROIC) is 47.49%.
| Return on Equity (ROE) | 37.31% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 47.49% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 3.31% |
| Revenue Per Employee | 1.53M |
| Profits Per Employee | 428,285 |
| Employee Count | 2,685 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:688278 has paid 140.59 million in taxes.
| Income Tax | 140.59M |
| Effective Tax Rate | 11.93% |
Stock Price Statistics
The stock price has decreased by -11.75% in the last 52 weeks. The beta is -0.17, so SHA:688278's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -11.75% |
| 50-Day Moving Average | 77.77 |
| 200-Day Moving Average | 77.98 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 2,294,506 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688278 had revenue of CNY 3.70 billion and earned 1.04 billion in profits. Earnings per share was 2.55.
| Revenue | 3.70B |
| Gross Profit | 3.70B |
| Operating Income | 1.25B |
| Pretax Income | 1.18B |
| Net Income | 1.04B |
| EBITDA | 1.31B |
| EBIT | 1.25B |
| Earnings Per Share (EPS) | 2.55 |
Balance Sheet
The company has 825.52 million in cash and 141.05 million in debt, giving a net cash position of 684.47 million or 1.68 per share.
| Cash & Cash Equivalents | 825.52M |
| Total Debt | 141.05M |
| Net Cash | 684.47M |
| Net Cash Per Share | 1.68 |
| Equity (Book Value) | 3.01B |
| Book Value Per Share | 7.40 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 33.92% and 28.08%.
| Gross Margin | 100.00% |
| Operating Margin | 33.92% |
| Pretax Margin | 31.88% |
| Profit Margin | 28.08% |
| EBITDA Margin | 35.53% |
| EBIT Margin | 33.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 0.83%.
| Dividend Per Share | 0.62 |
| Dividend Yield | 0.83% |
| Dividend Growth (YoY) | 51.22% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 1.00% |
| Earnings Yield | 3.45% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |